Pui Leng Loke

USPTO Granted Patents = 15 (Patent Applications = 2)

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 9 (Patent Applications = 13)

Average Co-Inventor Count = 9.6

ph-index = 4

Forward Citations = 28(Granted Patents)

Location History:

Oxfordshire, GB (2013 - 2019)
Abingdon, GB (2013 - 2021)

Company Filing History:

9 out of 1,535

Boehringer Ingelheim International Gmbh

patents

3 out of 6

Padlock Therapeutics, Inc.

where one patent can have more than one assignee

Years Active: 2013-2021

Loading Chart...

15 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 11026937 - Heteroaryl inhibitors of PAD4 (2021-06-08),

2. 10703741 - Covalent inhibitors of PAD4 (2020-07-07),

3. 10472341 - Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases (2019-11-12),

4. 10287299 - Substituted benzo[b][1,4]oxazines and pyrido[3,2-b][1,4]oxazines as modulators of tumor necrosis factor activity (2019-05-14),

5. 9963448 - Bicyclic inhibitors of PAD4 (2018-05-08),

6. 9174980 - Heterocyclic compounds as inhibitors of leukotriene production (2015-11-03),

7. 9073895 - Biarylamide inhibitors of leukotriene production (2015-07-07),

8. 8901313 - 6,5-heterocyclic propargylic alcohol compounds and uses therefor (2014-12-02),

9. 8829200 - Benzimidazole inhibitors of leukotriene production (2014-09-09),

10. 8658661 - Oxadiazole inhibitors of leukotriene production (2014-02-25),

11. 8609696 - Serotonin 5-HT2B receptor inhibitors (2013-12-17),

12. 8580829 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

13. 8580825 - Oxadiazole inhibitors of leukotriene production (2013-11-12),

14. 8575201 - Oxadiazole inhibitors of leukotriene production (2013-11-05),

15. 8420655 - Benzimidazole inhibitors of leukotriene production (2013-04-16),

Title: Pui Leng Loke: A Trailblazer in Innovations for a Sustainable Future

Introduction: Pui Leng Loke is a visionary inventor based in Abingdon, GB, whose relentless pursuit of innovation and commitment to creating a more sustainable future through her inventions make her a true inspiration in the world of technology. With a total of 15 patents to her name, Loke's impact on the industry is poised to endure for years to come.

Latest Patents:

1. Heteroaryl inhibitors of PAD4: Loke's latest patent introduces compounds useful as inhibitors of PAD4, alongside compositions and methods for treating PAD4-related disorders.

2. Covalent inhibitors of PAD4: Additionally, Loke's patent entails compounds that serve as inhibitors of PAD4, offering compositions and methods for addressing PAD4-related disorders.

Career Highlights: Loke has made significant contributions to the field through her work with esteemed companies like Boehringer Ingelheim International GmbH and Padlock Therapeutics, Inc. Her innovative solutions have garnered recognition for their potential to revolutionize the industry and pave the way for sustainable advancements in technology.

Collaborations: Throughout her career, Loke has collaborated closely with notable individuals such as Heather Tye and Zhidong Chen. These collaborations have not only enriched her work but have also led to the development of groundbreaking inventions that hold promise for the future.

Conclusion: Pui Leng Loke's unwavering dedication to innovation and her focus on creating a more sustainable future underscore her as a trailblazer in the industry. Her inventive spirit, coupled with her collaborative efforts and remarkable contributions, position her as an exemplary figure whose impact will continue to shape the technological landscape for generations to come.

This text is generated by artificial intelligence and may not be accurate.